<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34531126</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8865</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Semergen</Title><ISOAbbreviation>Semergen</ISOAbbreviation></Journal><ArticleTitle>[Long COVID: Is it really myalgic encephalomyelitis? Bibliographic review and considerations].</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>69</EndPage><MedlinePgn>63-69</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semerg.2021.03.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1138-3593(21)00091-5</ELocationID><Abstract><AbstractText>Clinical sequelae of a disease as widespread as COVID-19 can be of great importance for primary care due to their prevalence and the morbidity they entail. The definition of long COVID and the establishment of its temporality are various, but some authors consider possible that this syndrome is actually myalgic encephalomyelitis. Similarities are observed when comparing the International Consensus Criteria for the diagnosis of myalgic encephalomyelitis with the symptoms described for long COVID. Blood tests, pulse oximetry, chest radiography, and thoracic ultrasound are recommended in patients with persistent symptoms after acute infection. Management in both conditions consists of treating the main symptoms. The possibility that COVID-19 can lead to a chronic condition such as myalgic encephalomyelitis makes long-term follow-up of patients who have suffered from this infection essential.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria (SEMERGEN). Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Espinosa Rodr&#xed;guez</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>M&#xe9;dico interno residente de primer a&#xf1;o en Medicina Familiar y Comunitaria, Centro de Salud Floridablanca, Murcia, Espa&#xf1;a. Electronic address: p.espinosarodriguez@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Aguilar</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>M&#xe9;dico interno residente de primer a&#xf1;o en Medicina Familiar y Comunitaria, Centro de Salud Floridablanca, Murcia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripoll Mu&#xf1;oz</LastName><ForeName>M P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>M&#xe9;dico adjunto, especialista en Medicina Familiar y Comunitaria, Centro de Salud Floridablanca, Murcia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Navarro</LastName><ForeName>M &#xc1;</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>M&#xe9;dico adjunto, especialista en Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terapia del Dolor, Unidad del Dolor Cr&#xf3;nico, Hospital General Universitario Morales Meseguer, Murcia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>COVID persistente: &#xbf;es en realidad una encefalomielitis mi&#xe1;lgica? Revisi&#xf3;n bibliogr&#xe1;fica y consideraciones.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Semergen</MedlineTA><NlmUniqueID>9610769</NlmUniqueID><ISSNLinking>1138-3593</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Las secuelas cl&#xed;nicas de una enfermedad tan extendida como la COVID-19 pueden ser de gran importancia para la atenci&#xf3;n primaria por su prevalencia y la morbilidad que conllevan. La definici&#xf3;n de <i>COVID persistente</i> y el establecimiento de su temporalidad son dispares pero algunos autores consideran plausible que este s&#xed;ndrome sea en realidad una encefalomielitis mi&#xe1;lgica. Se observan similitudes al comparar los Criterios Internacionales de Consenso para el diagn&#xf3;stico de encefalomielitis mi&#xe1;lgica con los s&#xed;ntomas descritos para la <i>COVID persistente</i>. Se recomienda la realizaci&#xf3;n de anal&#xed;tica sangu&#xed;nea, pulsioximetr&#xed;a, radiograf&#xed;a de t&#xf3;rax y ecograf&#xed;a tor&#xe1;cica en los pacientes con s&#xed;ntomas persistentes despu&#xe9;s de la infecci&#xf3;n aguda. El manejo en ambos cuadros consiste en el tratamiento de los principales s&#xed;ntomas. La posibilidad de que la COVID-19 pueda dar lugar a un cuadro cr&#xf3;nico como la encefalomielitis mi&#xe1;lgica hace imprescindible un seguimiento a largo plazo de los pacientes que han presentado esta infecci&#xf3;n.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria (SEMERGEN). Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID persistente</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Encefalomielitis mi&#xe1;lgica</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de COVID postagudo</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de fatiga cr&#xf3;nica</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>17</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34531126</ArticleId><ArticleId IdType="pmc">PMC8437705</ArticleId><ArticleId IdType="doi">10.1016/j.semerg.2021.03.006</ArticleId><ArticleId IdType="pii">S1138-3593(21)00091-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern [published correction appears in Lancet. 2020 Jan 29] Lancet. 2020;395(10223):470&#x2013;473. doi: 10.1016/S0140-6736(20)30185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30185-9</ArticleId><ArticleId IdType="pmc">PMC7135038</ArticleId><ArticleId IdType="pubmed">31986257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad, Consumo y Bienestar Social. Enfermedad por nuevo coronavirus, COVID-19. Situaci&#xf3;n actual, 2021 [consultado 24 Ene 2021]. Disponible en: www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm</Citation></Reference><Reference><Citation>Zheng Q., Lu Y., Lure F., Jaeger S., Lu P. Clinical and radiological features of novel coronavirus pneumonia. J Xray Sci Technol. 2020;28:391&#x2013;404. doi: 10.3233/XST-200687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/XST-200687</ArticleId><ArticleId IdType="pmc">PMC7369043</ArticleId><ArticleId IdType="pubmed">32538893</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballv&#xe9; A., Llaurad&#xf3; A., Gallardo U., Ariton V.J., Lallana D.M., et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410&#x2013;1421. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS England. National guidance for post-COVID syndrome assessment clinics. 2020. [consultado 24 Ene 2021]. Disponible en https://www.england.nhs.uk/coronavirus/publication/national-guidance-for-post-covid-syndrome-assessment-clinics/.</Citation></Reference><Reference><Citation>Brito-Zer&#xf3;n P., Conangla L., Kostov B., Moragas A., Ramos-Casals M., Sequeira E., et al.   Sociedad Catalana de Medicina Familiar y Comunitaria.; 2020. Manifestaciones persistentes de la COVID-19. Gu&#xed;a de pr&#xe1;ctica cl&#xed;nica. [consultado 24 Ene 2021]. Disponible en  https://www.semfyc.es/wp-content/uploads/2021/01/Covid19-persistente.pdf.</Citation></Reference><Reference><Citation>Fieiras C., Panoso C.N., Rosell C.I., Franco J.V. Manejo de los s&#xed;ntomas persistentes de COVID-19 en atenci&#xf3;n primaria. Evidencia, Actualizaci&#xf3;n en la Pr&#xe1;ctica Ambulatoria. 2020;23:e002103.</Citation></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria. S&#xed;ntomas persistentes en la COVID-19, 2020 [consultado 24 Ene 2021]. Disponible en: www.semergen.es/files/docs/COVID-19/Documentos/Manejo%20de%20los%20s%c3%adntomas%20persistentes%20de%20COVID.pdf</Citation></Reference><Reference><Citation>Perrin R., Riste L., Hann M., Walther A., Mukherjee A., Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. doi: 10.1016/j.mehy.2020.110055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Organizaci&#xf3;n Mundial de la Salud, centro de prensa. El brote de SRAS ha sido contenido en todo el mundo, 2003 [consultado 24 de Ene 2021]. Disponible en: www.who.int/mediacentre/news/releases/2003/pr56/es/</Citation></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes G.P., Kaplan J.E., Gantz N.M., Komaroff A.L., Schonberger L.B., Straus S.E., et al. Chronic fatigue syndrome: A working case definition. Ann Intern Med. 1988;108:387&#x2013;389. doi: 10.7326/0003-4819-108-3-387.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-108-3-387</ArticleId><ArticleId IdType="pubmed">2829679</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., de Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hives L., Bradley A., Richards J., Sutton C., Selfe J., Basu B., et al. Can physical assessment techniques aid diagnosis in people with chronic fatigue syndrome/myalgic encephalomyelitis? A diagnostic accuracy study. BMJ Open. 2017;7:1&#x2013;7. doi: 10.1136/bmjopen-2017-017521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017521</ArticleId><ArticleId IdType="pmc">PMC5695376</ArticleId><ArticleId IdType="pubmed">29133321</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2020;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Late Sequelae of COVID-19, 2020 [consultado 24 Ene 2021]. Disponible en: www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html</Citation></Reference><Reference><Citation>National Institutes of Health. Clinical spectrum of SARS-CoV-2 infection, 2020 [consultado 24 Ene 2021]. Disponible en: www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>GOV.UK. COVID-19: Long term health effects, 2020 [consultado 24 Ene 2021]. Disponible en: www.gov.uk/government/publications/covid-19-long-term-health-effects/covid-19-long-term-health-effects</Citation></Reference><Reference><Citation>McIntosh K. Coronavirus disease 2019 (COVID-19): Clinical features. Post TW, editor. UpToDate. Waltham, MA: UpToDate Inc., 2020 [consultado 24 Ene 2021]. Disponible en: www.uptodate.com/contents/coronavirus-disease-2019-covid-19-clinical-features?search=covid&amp;source=search_result&amp;selectedTitle=1&#x223c;150&amp;usage_type=default&amp;display_rank=1#H1615019290</Citation></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files C., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014;United States. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria. Protocolo de actuaci&#xf3;n en pacientes con COVID-19 asistidos en atenci&#xf3;n primaria, 2021 [consultado 24 Ene 2021]. Disponible en: www.semergen.es/files/docs/COVID-19/Documentos/ferrer-covid-19.pdf</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Encefalomielitis mi&#xe1;lgica/s&#xed;ndrome de fatiga cr&#xf3;nica, 2020 [consultado 24 Ene 2021]. Disponible en: www.cdc.gov/me-cfs/es/tratamiento/index.html</Citation></Reference><Reference><Citation>Larun L., Brurberg K.G., Odgaard-Jensen J., Price J.R. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews. 2019;(Issue 10) doi: 10.1002/14651858. Art. No.: CD003200, CD003200.pub8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858</ArticleId><ArticleId IdType="pmc">PMC6953363</ArticleId><ArticleId IdType="pubmed">31577366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman SJ. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Post TW, editor. UpToDate. Waltham, MA: UpToDate Inc., 2020 [consultado 24 Ene 2021]. Disponible en: www.uptodate.com/contents/treatment-of-myalgic-encephalomyelitis-chronic-fatigue-syndrome?search=myalgic%20encephalomyelitis&amp;source=search_result&amp;selectedTitle=1&#x223c;113&amp;usage_type=default&amp;display_rank=1</Citation></Reference><Reference><Citation>Kael AT. Chronic fatigue syndrome. DynaMed [Internet]. Ipswich (MA): EBSCO Information Services; 1995, 2019 [consultado 24 Ene 2021]. Disponible en: www.dynamed.com/condition/chronic-fatigue-syndrome#MANAGEMENT_RECOMMENDATIONS;2019</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>